The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.
Chinese consumer spending once powered luxury companies to all-time highs. With sluggish economic growth, the outlook for the sector might not be the same.